Analyst Price Target is $17.50
▲ +62.04% Upside Potential
This price target is based on 2 analysts offering 12 month price targets for Kazia Therapeutics in the last 3 months. The average price target is $17.50, with a high forecast of $18.00 and a low forecast of $17.00. The average price target represents a 62.04% upside from the last price of $10.80.
Current Consensus is
The current consensus among 2 investment analysts is to buy stock in Kazia Therapeutics.